ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)
major depressive disorder (mdd), mdd, esmethadone, adjunctive therapy, rel-1017, nmda, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886297
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.